EPO and Miyoshi myopathy: ANK1 participates in the malignant progression of acute myeloid leukemia in the elderly and in children with Down syndrome, related to erythropoietin, which provides a potential molecular link for MM secondary acute myeloid leukemia and mediating poor prognosis [4, 59, 60].